Low-dose ultrasound molecular imaging in mouse tumor model

Targeted microbubbles are currently used as ultrasound contrast agents in pre-clinical studies to visualize disease markers present on the blood vessel endothelium. Rapid clinical translation of targeted microbubble imaging requires a minimization of the diagnostically effective microbubble dose. In this study, we demonstrate an imaging method that improves signal-to-noise ratio (SNR) for microbubble detection and allows for accurate prediction of VEGFR2 targeting in a murine tumor model at 2.5% of the previously established minimum microbubble dose.

[1]  John A Hossack,et al.  The Use of Acoustic Radiation Force Decorrelation-Weighted Pulse Inversion for Enhanced Ultrasound Contrast Imaging , 2017, Investigative radiology.

[2]  F. Kiessling,et al.  Low-Dose Molecular Ultrasound Imaging with E-Selectin-Targeted PBCA Microbubbles , 2016, Molecular Imaging and Biology.

[3]  Lindsey T. Brinton,et al.  Development of target-specific liposomes for delivering small molecule drugs after reperfused myocardial infarction. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Lotfi Abou-Elkacem,et al.  Ultrasound molecular imaging: Moving toward clinical translation. , 2015, European journal of radiology.

[5]  François Tranquart,et al.  Vascular endothelial growth factor receptor type 2-targeted contrast-enhanced US of pancreatic cancer neovasculature in a genetically engineered mouse model: potential for earlier detection. , 2015, Radiology.

[6]  J. Hossack,et al.  Binding dynamics of targeted microbubbles in response to modulated acoustic radiation force , 2014, Physics in medicine and biology.

[7]  Sanjiv S Gambhir,et al.  Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model. , 2013, Cancer research.

[8]  Sunil Unnikrishnan,et al.  Microbubbles as ultrasound contrast agents for molecular imaging: preparation and application. , 2012, AJR. American journal of roentgenology.

[9]  S. Bunting,et al.  Molecular Imaging of the Initial Inflammatory Response in Atherosclerosis: Implications for Early Detection of Disease , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[10]  J. Lindner,et al.  Detection of recent myocardial ischaemia by molecular imaging of P-selectin with targeted contrast echocardiography. , 2007, European heart journal.

[11]  Mark Borden,et al.  Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. , 2007, Annual review of biomedical engineering.

[12]  J. Lindner,et al.  Molecular Imaging of Inflammation in Atherosclerosis With Targeted Ultrasound Detection of Vascular Cell Adhesion Molecule-1 , 2007, Circulation.

[13]  Jørgen Arendt Jensen,et al.  Synthetic aperture ultrasound imaging. , 2006, Ultrasonics.

[14]  William R. Wagner,et al.  Modulating Targeted Adhesion of an Ultrasound Contrast Agent to Dysfunctional Endothelium , 2002, Annals of Biomedical Engineering.

[15]  P. Phillips,et al.  Contrast pulse sequences (CPS): imaging nonlinear microbubbles , 2001, 2001 IEEE Ultrasonics Symposium. Proceedings. An International Symposium (Cat. No.01CH37263).

[16]  J. Hossack,et al.  Ultrasound-based measurement of molecular marker concentration in large blood vessels: a feasibility study. , 2015, Ultrasound in medicine & biology.

[17]  W.D. O'Brien,et al.  Synthetic aperture techniques with a virtual source element , 1998, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.